Twice-yearly injections for AIDS were 100% effective in preventing infections in women in a study of 5,000 participants in South Africa and Uganda.
Gilead's lenacapavir, currently used for HIV treatment, may soon be approved as a preventive measure pending positive results from men's testing.
Collection
[
|
...
]